Composition of novel carbohydrate drug for treatment of human diseases
AssigneeGalectin Therapeutics, Inc.
InventorsEliezer Zomer, Peter G. Traber, Anatole A. Klyosov, Elena Chekhova
Life of this patent
Estimating the term…
Abstract
Aspects of the invention provide compositions for use in the treatment galectin-dependent diseases. In particular, compositions comprising a selectively depolymerized, branched galactoarabino-rhamnogalacturonate whose backbone is predominantly comprised of 1,4-linked galacturonic acid (GalA) moieties, with a lesser backbone composition of alternating 1,4-linked GalA and 1,2-linked rhamnose (Rha), which in-turn is linked to any number of side chains, including predominantly 1,4-b-D-galactose (Gal) and 1,5-a-L-arabinose (Ara) residues.
Claims30
A process comprising
- a) treating an aqueous solution of pectin with ascorbic acid, or hydrogen peroxide or a combination of ascorbic acid and hydrogen peroxide;
- and
- b) treating the resulting solution at a pH of ranging from 8 to 10;
- thereby generating a compound comprising a complex carbohydrate backbone of 1,4-linked galacturonic acid (GalA) and 1,4-linked methyl galacturonate (MeGalA) residues with interspersed α-1,2 linked rhamnose within the carbohydrate backbone, the rhamnose residues carrying primary branching of oligomers of 1,4-β-D-galactose residues, 1,5-α-L-arabinose residues, or combinations thereof,
- wherein the molar percent of the oligomers of 1,4-β-D-galactose residues and 1,5-α-L-arabinose residues is greater than 10% of the total carbohydrate molar content,
- wherein the compound has a degree of methoxylation ranging from 33% to 66%, and
- wherein the 1,4-β-D-galactose and 1,5-α-L-arabinose residues are present in a 2:1 to a 3:1 ratio.
A process comprising
- a) treating an aqueous solution of high methoxylated pectin with ascorbic acid, or hydrogen peroxide or a combination of ascorbic acid and hydrogen peroxide;
- and
- b) treating the resulting solution at a pH ranging from 8 to 10 for 10 min to 30 min, thereby generating a compound comprising a complex carbohydrate backbone of 1,4-linked galacturonic acid (GalA) and 1,4-linked methyl galacturonate (MeGalA) residues, wherein the compound has a degree of methoxylation ranging from 33% to 66%.
Dependencies are inferred from the claim text.